| Title |
Ganglion blocks as a treatment of pain: current perspectives
|
|---|---|
| Published in |
Journal of Pain Research, December 2017
|
| DOI | 10.2147/jpr.s134775 |
| Pubmed ID | |
| Authors |
Osman Hakan Gunduz, Ozge Kenis-Coskun |
| Abstract |
The inputs from sympathetic ganglia have been known to be involved in the pathophysiology of various painful conditions such as complex regional pain syndrome, cancer pain of different origin, and coccygodynia. Sympathetic ganglia blocks are used to relieve patients who suffer from these conditions for over a century. Many numbers of local anesthetics such as bupivacaine or neurolytic agents such as alcohol can be chosen for a successful block. The agent is selected according to its duration of effect and the purpose of the injection. Most commonly used sympathetic blocks are stellate ganglion block, lumbar sympathetic block, celiac plexus block, superior hypogastric block, and ganglion Impar block. In this review, indications, methods, effectiveness, and complications of these blocks are discussed based on the data from the current literature. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 25% |
| Singapore | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 113 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 14 | 12% |
| Student > Master | 13 | 12% |
| Student > Postgraduate | 11 | 10% |
| Professor > Associate Professor | 10 | 9% |
| Researcher | 9 | 8% |
| Other | 22 | 19% |
| Unknown | 34 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 52% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Engineering | 2 | 2% |
| Neuroscience | 2 | 2% |
| Agricultural and Biological Sciences | 2 | 2% |
| Other | 9 | 8% |
| Unknown | 37 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2020.
All research outputs
#12,865,484
of 23,011,300 outputs
Outputs from Journal of Pain Research
#824
of 1,763 outputs
Outputs of similar age
#197,850
of 437,944 outputs
Outputs of similar age from Journal of Pain Research
#28
of 51 outputs
Altmetric has tracked 23,011,300 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,763 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.0. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,944 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.